PT-141 (bremelanotide) is a melanocortin-based therapy that supports sexual desire and arousal through the central nervous system — not blood flow. Unlike ED medications such as sildenafil and tadalafil, which act on the vascular system, PT-141 works on the brain pathways that govern libido. This makes it an option for men whose challenges are driven by low desire rather than purely physical factors. Delivered as a discreet, on-demand subcutaneous injection, it can be used on its own or alongside a PDE5 inhibitor.
Acts on desire, not just blood flow: PT-141 activates melanocortin receptors in the brain to increase sexual desire and arousal — addressing the central drivers of low libido that PDE5 inhibitors don't reach.
Works alongside ED medication: Because it works through a different pathway, PT-141 can complement sildenafil or tadalafil for men who want support with both desire and erectile function.
On-demand dosing: Taken as needed ahead of intimacy rather than daily, giving flexibility and spontaneity.
Non-hormonal: PT-141 does not alter testosterone or other hormone levels, making it a non-hormonal option for restoring desire.
Discreet, self-administered format: A small subcutaneous injection that is simple to self-administer at home.